Serra G, et al. – The authors have recently reported that memantine has a clinically relevant antimanic and long–lasting mood–stabilizing effect in treatment–resistant bipolar disorders, both as augmenting agent and as monotherapy. In this article, they report the case of a young woman suffering from bipolar II disorder with associated fibromyalgia, in whom memantine showed an acute antimanic and a long–term prophylactic effect on both bipolar disorder as well as the associated fibromyalgia syndrome.
|
No comments:
Post a Comment